CBLI Related StreetInsider.com Reports
-
Cleveland Biolabs, Inc. (CBLI) Posts Q1 Loss of 22c/Share
-
Cleveland BioLabs (CBLI), Incuron Receive FDA Approval for CBL0137 IND
-
StreetInsider.com Pre-Open Movers 03/21: (ITMN) (CBLI) (PERY) Higher; (ORCL) (TUMI) (GES) Lower (more...)
-
Streetinsider.com After-Hours Movers 3/20: (CBLI) (JCP) Higher; (TLYS) (TUMI) (ORCL) Lower (more...)
-
Cantor Fitzgerald Starts Cleveland BioLabs (CBLI) at Buy
-
Cleveland Biolabs, Inc. (CBLI) Swings to Q4 Profit
-
StreetInsider.com Pre-Open Movers 12/6: (WLT) (ZNGA) (GRMN) Higher; (MW) (AAPL) (DB) Lower (more...)
-
Oppenheimer Starts Cleveland BioLabs (CBLI) at Outperform
-
Notable Analyst Rating Changes 12/04: (FRAN) (GFI) (SFD) Upgraded; (IACI) (CLF) (RGC) Downgraded
-
Burrill Starts Cleveland BioLabs (CBLI) at Market Outperform
-
Cleveland BioLabs (CBLI), Panacela Labs Receive $4.6M Contract in Russia for Xenomycins Development
-
Trading Radar for 11/08: Disney (DIS), Lannett (LCI), Allscripts (MDRX), Wendy's (WEN) Report
-
Unusual 11 Mid-Day Movers 10/19: (GURE) (RVBD) (CALL) Higher; (CBLI) (PXLW) (MIG) Lower
-
Pre-Open Movers 10/19: (RVBD) (CALL) (SNDK) Higher; (CBLI) (CMG) (ATHN) Lower (more...)
-
Cleveland BioLabs (CBLI) Prices $15 Million Common Stock Offering
-
Cleveland Biolabs (CBLI) JV Initiates CBL0137 Phase 1
-
Cleveland Biolabs (CBLI), Incuron Report Quinacrine Given Orphan Drug Status by FDA
-
Cleveland BioLabs (CBLI) Recieves FDA Minutes and Advice Letter for Entolimod
-
Unusual 11 Mid-Day Movers 09/13: (CUR) (CBLI) (PMFG) Higher; (CCRT) (PSTI) (BPI) Lower
-
Cleveland Bio (CBLI) Gets Advce Letter from FDA for Entolimod as Radiation Countermeasure
-
Cleveland Biolabs, Inc. (CBLI) Posts Wider than Expected Q2 Loss
-
Cleveland BioLabs (CBLI) Reports Publication of CBLB502 Efficacy as Radiation Countermeasure
-
Cleveland BioLabs (CBLI) Signs $4 Million Contract with Russian Ministry of Industry and Trade
-
Cleveland BioLabs (CBLI) Says New Studies of CBL0137 Show Possible Curative Effects
-
Cleveland BioLabs (CBLI) Appoints Yakov Kogan as Permanent CEO
-
Unusual 11 Mid-Day Movers 06/05: (AMRS) (WPRT) (BPAX) Higher; (EDS) (SHFL) (CBLI) Lower
-
Morning Movers 06/05: (BPAX) (AMRS) (PSUN) Higher; (EDS) (SHFL) (CBLI) (TAST) Lower
-
Unusual 11 Mid-Day Movers 06/04: (CBLI) (MTOX) (CRED) Higher; (BONT) (CQP) (AMRS) Lower
-
Morning Movers 06/04: (CBLI) (MTOX) (CRED) Higher; (BONT) (CYTR) Lower
-
Cleveland Biolabs (CBLI) Shares Rally as Efficacy Study for CBLB502 Showed Strong Survival Results
-
Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share
-
Cleveland BioLabs (CBLI) Gets Russian Regulatory Approval for CBLC137 Phase 1B
-
Unusual 11 Mid-Day Movers 04/01: (MAGS) (CREG) (GMXR) Higher; (CBLI) (UCFC) (PATK) Lower
-
Morning Movers 04/04: (MAGS) (GMXR) Higher; (CBLI) (PATK) (SNDK) (WBMD) Lower
-
Pre-Open Movers 4/4: (GMXR) (DDIC) (SBUX) Higher; (CBLI) (TSLA) (SNDK) Lower (more...)
-
Cleveland BioLabs (CBLI) Shares Volatile Following New Outperform Rating at Rodman & Renshaw
-
Cleveland Biolabs, Inc. (CBLI) Misses Q4 EPS by 2c
-
Unusual 11 Midday Movers 02/27: (ALIM) (BPAX) (ATPG) (CAAS) Higher; (DNDN) (IMI) (BCPC) Lower
-
Cleveland Biolabs (CBLI) Fonstein to Step Down as CEO, Will Remain Pres; Kogan Named Interim CEO
-
Cleveland BioLabs (CBLI) Enters Joint Stock Agreement with RUSNANO for Panacela Labs Funding
-
Unusual 11 Mid-Day Movers 09/09: (ULTA) (CGA) (CONN) Higher; (AATI) (VRSN) (MTRX) Lower
-
Cleveland BioLabs (CBLI) Receives Additional $1.5 Million in Funding for Development of CBLB502
-
Unusual 11 Mid-Day Movers 06/17: (GNMK) (NCT) (BPZ) Higher; (CTFO) (RIMM) (DEER) Low
-
Morning Movers 06/17: (GNMK) (NCT) (GENE) Higher; (RIMM) (CBLI) (QIHU) (LPS) Lower
-
Cleveland BioLabs (CBLI) Slammed on Equity Placement News
-
Cleveland BioLabs (CBLI) Announces 8.81M Common in Private Offerings
-
Unusual 11 Mid-Day Movers 05/31: (AGYS) (YONG) (CV) Higher; (CBLI) (NOK) (TTHI) Lower
-
Morning Movers 05/31: (YONG) (CV) (AGYS) (ELTK) Higher; (LAS) (NOK) (CBLI) Lower
-
Pre-Open Movers 5/31: (FTLK) (CV) (FSLR) Higher; (NOK) (CBLI) (MDT) Lower (more...)
-
Cleveland BioLabs (CBLI), BARDA Conclude Advanced CBLB502 Funding Talks
Back to CBLI Stock Lookup
